Note regarding participation in the study: Participants are selected at random using a scientific procedure so that they represent the children and young people in their age group from a previously and randomly selected residential area. It is therefore unfortunately not possible to volunteer for the study.
In May 2022, PARC, the European Partnership for the Assessment of Risks from Chemicals, was launched, involving 200 institutions from 28 countries and three EU authorities. As part of this project, comparable human biomonitoring studies are being carried out in 12-20 partner countries (depending on the age group). This is a follow-up to the Aligned Studies carried out as part of the European HBM4EU initiative. Human biomonitoring (HBM) means that body fluids or tissue, such as urine or blood, are analysed for their content of pollutants. This allows conclusions to be drawn concerning the overall exposure to such substances in the human body.